Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Ironwood Pharmaceuticals Inc
Revenue
Ironwood Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
Revenue
$442.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
34%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Ironwood Pharmaceuticals Inc
Revenue Breakdown
Breakdown by Geography
Ironwood Pharmaceuticals Inc
Total Revenue:
442.7m
USD
|
North America:
433.2m
USD
|
Europe And Other:
2.8m
USD
|
Breakdown by Segments
Ironwood Pharmaceuticals Inc
Total Revenue:
442.7m
USD
|
Collaborative Arrangements Revenue:
442.7m
USD
|
Collaborative Arrangement, Other Agreements:
2.5m
USD
|
Royalty:
2.2m
USD
|
Collaborative Arrangement, Co-Promotion Agree...:
2m
USD
|
Collaborative Arrangement, Collaboration And ...:
1.8m
USD
|
See Also
What is Ironwood Pharmaceuticals Inc's Revenue?
Revenue
442.7m
USD
Based on the financial report for Dec 31, 2023, Ironwood Pharmaceuticals Inc's Revenue amounts to 442.7m USD.
What is Ironwood Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
34%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Ironwood Pharmaceuticals Inc have been 4% over the past three years , 5% over the past five years , and 34% over the past ten years .